English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Now On Demand
Creating Time: New DxI 9000 Immunoassay Analyzer
Watch the global unveiling of a brand-new high throughput immunoassay analyzer at WORLDLAB • EUROMEDLAB.
All
From Evidence to Practice: How MDW Implementation Can Impact SEPSIS Detection and Risk Assessment
In this workshop, attendees learned how Udine University Hospital incorporated MDW in their standard operating procedures, transitioning its application in early sepsis detection from clinical studies to medical practice. In addition, the experience from University Hospital 12th October shared benefits arising from Monocyte Distribution Width (MDW) use in daily routine. MDW is the only regulatory cleared hematological biomarker available with the first blood draw that helps to identify severity of infection and risk of sepsis in adult patients in ED.
Chair:
Giustino Parruti, M.D., Ph.D.
AUSL Pescara, Pescara, Italy
Speakers:
Professor Francesco Curcio
University of Udine, Udine, Italy
Sandra Gomez Rojas, M.D.
University Hospital 12th October, Madrid, Spain
Setting a New Standard for Automated Immunoassay - Innovative Technology Designed for Evolving Healthcare Needs
During this workshop, attendees learned about the analytical and operational performance of Beckman Coulter’s high throughput immunoassay analyzer. Attendees were also able to hear more detail on the experience and studies performed by Mayo University Hospital and University Hospitals of Morecambe Bay.
Chair:
Janet Eglin
Technical Services Manager
University Hospitals Morecambe Bay, UK
Speakers:
Mr. Ray Divilley
Mayo University Hospital, Ireland
Dr. Andrew Brown
University Hospitals Morecambe Bay, UK
Intelligent Automation for All
In this workshop, attendees learned about the Beckman Coulter DxA 5000 Family and heard from customers’ experiences with the products. Attendees also learned about DxA 5000 implementations at customer sites, how the users have operated the DxA 5000 in their lab and the impact the DxA 5000 has had on their outcomes.
Chair:
Professor Harald Renz
Head of the Institute of Laboratory Medicine and Pathobiochemistry
University of Marburg and President of DGKL, Germany
Speakers:
Dr. Hervé Vermeulen
Laboratory Manager and Quality Manager
Centre Hospitalier de Calais, France
Michael Cornes, Ph.D.
Consultant Clinical Scientist & Pathology Clinical Director
Worcestershire Acute Hospitals NHS Trust, UK
